News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
184,665 Results
Type
Article (4284)
Company Profile (26)
Press Release (180355)
Multimedia
Podcasts (2)
Webinars (1)
Section
Business (74354)
Career Advice (81)
Deals (12429)
Drug Delivery (10)
Drug Development (22864)
Employer Resources (9)
FDA (3975)
Job Trends (4403)
News (111461)
Policy (7583)
Tag
Academia (371)
Academic (1)
Accelerated approval (1)
Adcomms (2)
Allergies (37)
Alliances (8876)
ALS (18)
Alzheimer's disease (367)
Antibody-drug conjugate (ADC) (28)
Approvals (4032)
Artificial intelligence (41)
Autoimmune disease (5)
Automation (4)
Bankruptcy (99)
Best Places to Work (4023)
Biosimilars (22)
Biotechnology (18)
Bladder cancer (36)
Brain cancer (7)
Breast cancer (153)
Cancer (986)
Cardiovascular disease (74)
Career advice (66)
Career pathing (4)
CAR-T (38)
CDC (3)
Cell therapy (111)
Cervical cancer (6)
Clinical research (20228)
Collaboration (226)
Company closure (1)
Compensation (135)
Complete response letters (4)
COVID-19 (510)
CRISPR (15)
C-suite (75)
Cystic fibrosis (25)
Data (1257)
Depression (16)
Diabetes (115)
Diagnostics (1821)
Digital health (7)
Diversity, equity & inclusion (2)
Drug discovery (16)
Drug pricing (14)
Drug shortages (2)
Duchenne muscular dystrophy (37)
Earnings (57834)
Editorial (4)
Employer branding (1)
Employer resources (7)
Events (24933)
Executive appointments (169)
FDA (4582)
Frontotemporal dementia (4)
Funding (184)
Gene editing (31)
Generative AI (2)
Gene therapy (110)
GLP-1 (179)
Government (679)
Guidances (155)
Healthcare (5079)
Huntington's disease (3)
IgA nephropathy (7)
Immunology and inflammation (37)
Indications (11)
Infectious disease (555)
Inflammatory bowel disease (54)
Inflation Reduction Act (2)
Influenza (19)
Intellectual property (41)
Interviews (9)
IPO (7662)
IRA (4)
Job creations (609)
Job search strategy (59)
Kidney cancer (6)
Labor market (12)
Layoffs (111)
Leadership (1)
Legal (1483)
Liver cancer (20)
Lung cancer (156)
Lymphoma (94)
Machine learning (1)
Management (2)
Manufacturing (68)
MASH (42)
Medical device (4119)
Medtech (4120)
Mergers & acquisitions (5047)
Metabolic disorders (233)
Multiple sclerosis (52)
NASH (8)
Neurodegenerative disease (30)
Neuropsychiatric disorders (5)
Neuroscience (565)
NextGen: Class of 2025 (1233)
Non-profit (667)
Now hiring (4)
Obesity (76)
Opinion (21)
Ovarian cancer (39)
Pain (30)
Pancreatic cancer (40)
Parkinson's disease (52)
Partnered (3)
Patents (97)
Patient recruitment (54)
Peanut (25)
People (9047)
Pharmaceutical (6)
Pharmacy benefit managers (1)
Phase I (5475)
Phase II (8548)
Phase III (7864)
Pipeline (1070)
Policy (14)
Postmarket research (699)
Preclinical (1784)
Press Release (21)
Prostate cancer (40)
Psychedelics (1)
Radiopharmaceuticals (63)
Rare diseases (114)
Real estate (815)
Recruiting (5)
Regulatory (6108)
Reports (12)
Research institute (300)
Resumes & cover letters (8)
Rett syndrome (8)
RNA editing (1)
RSV (15)
Schizophrenia (31)
Series A (16)
Series B (16)
Service/supplier (1)
Sickle cell disease (26)
Special edition (6)
Spinal muscular atrophy (44)
Sponsored (1)
Startups (389)
Stomach cancer (4)
Supply chain (8)
Tariffs (4)
The Weekly (2)
Vaccines (165)
Venture capital (10)
Weight loss (41)
Women's health (11)
Worklife (3)
Date
Today (29)
Last 7 days (223)
Last 30 days (1028)
Last 365 days (11405)
2025 (6398)
2024 (12435)
2023 (14249)
2022 (15023)
2021 (15442)
2020 (14629)
2019 (11549)
2018 (8555)
2017 (9851)
2016 (7839)
2015 (9547)
2014 (7173)
2013 (5389)
2012 (5767)
2011 (6151)
2010 (5754)
Location
Africa (94)
Alabama (26)
Arizona (56)
Arkansas (2)
Asia (10532)
Australia (1089)
California (2625)
Canada (761)
China (175)
Colorado (130)
Connecticut (119)
Delaware (89)
Europe (23807)
Florida (383)
Georgia (124)
Idaho (12)
Illinois (172)
India (6)
Indiana (202)
Iowa (7)
Japan (85)
Kansas (25)
Kentucky (7)
Louisiana (4)
Maine (40)
Maryland (362)
Massachusetts (1890)
Michigan (80)
Minnesota (140)
Missouri (40)
Montana (10)
Nebraska (3)
Nevada (44)
New Hampshire (21)
New Jersey (1006)
New Mexico (3)
New York (812)
North Carolina (382)
North Dakota (1)
Northern California (1146)
Ohio (55)
Oregon (6)
Pennsylvania (603)
Puerto Rico (5)
Rhode Island (9)
South America (195)
South Carolina (14)
Southern California (1043)
Tennessee (36)
Texas (524)
United States (10196)
Utah (82)
Virginia (74)
Washington D.C. (21)
Washington State (242)
Wisconsin (6)
184,665 Results for "31".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025
July 1, 2025
·
1 min read
Press Releases
SDP Japan Raises $31 Million in Series D Round
June 16, 2025
·
7 min read
Press Releases
Proteomics Market Surges to USD 31.41 Billion in 2025, Fueled by AI, Personalized Medicine & Biotech Expansion
July 11, 2025
·
1 min read
Press Releases
Bristol Myers Squibb to Report Results for Second Quarter 2025 on July 31, 2025
June 12, 2025
·
1 min read
Press Releases
Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update
June 27, 2025
·
15 min read
Press Releases
Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity
May 21, 2025
·
1 min read
Press Releases
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2025
May 15, 2025
·
4 min read
Press Releases
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025
May 15, 2025
·
11 min read
Press Releases
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025
May 12, 2025
·
2 min read
Press Releases
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025
May 20, 2025
·
23 min read
1 of 18,467
Next
